Component

Sepsis death or persistent organ dysfunction at day 28

Independent measured endpoint or substance; model, assay and exposure are retained in each linked finding.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What acts on it

  1. The primary composite occurred in 44.5% with IV C versus 38.5% with placebo (RR 1.21, 95% CI 1.04–1.40; P=0.01).

    Experimental context and source evidence
    experimental_model
    LOVIT: multicenter placebo-controlled randomized ICU trial; 872 randomized, 863 in primary analysis, with sepsis and vasopressor use.
    exposure
    IV vitamin C 50 mg/kg every six hours for up to 96 hours versus matched placebo.
    limitations
    The trial did not identify the molecular cause; pharmacologic IV exposure cannot be generalized to food vitamin C or correction of scurvy.
    nutrient_topic
    Vitamin C research collection; topical membership is not evidence of a direct dietary effect. · Vitamin C
    organism
    Homo sapiens
    plain_language
    In this sepsis population, the tested infusion increased the combined risk of death or ongoing organ-support needs.
    primary_references
    [c-lamontagne2022] Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit (2022). https://pubmed.ncbi.nlm.nih.gov/35704292/ DOI: 10.1056/nejmoa2200644
    tissue_or_cell_type
    Human blood or whole-person endpoints

    Vitamin C: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1695–1705

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · LOVIT: multicenter placebo-controlled randomized ICU trial; 872 randomized, 863 in primary analysis, with sepsis and vasopressor use. · source_derived_draft · unverified_draft

    ### c-lovit-primary-composite The primary composite occurred in 44.5% with IV C versus 38.5% with placebo (RR 1.21, 95% CI 1.04–1.40; P=0.01). Condition category: normal nutrient_topic: Vitamin C research collection; topical membership is not evidence of a direct dietary effect. plain_language: In this sepsis population, the tested infusion increased the combined risk of death or ongoing organ-support needs. organism: Homo sapiens tissue_or_cell_type: Human blood or whole-person endpoints experimental_model: LOVIT: multicenter placebo-controlled randomized ICU trial; 872 randomized, 863 in primary analysis, with sepsis and vasopressor use. limitations: The trial did not identify the molecular cause; pharmacologic IV exposure cannot be generalized to food vitamin C or correction of scurvy. exposure: IV vitamin C 50 mg/kg every six hours for up to 96 hours versus matched placebo. [c-lamontagne2022] Intravenous Vitamin C in Adults with Sepsis in the Intensive Care Unit (2022). https://pubmed.ncbi.nlm.nih.gov/35704292/ DOI: 10.1056/nejmoa2200644
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards